Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tomasz Obrzut"'
Autor:
Gautam Bhattacharya, Dan L. Sackett, Manar M. Salem, Dawn A. Delfín, Cyrus J. Bacchi, Donna Rattendi, Karl A. Werbovetz, Tomasz Obrzut
Publikováno v:
Molecular Pharmacology. 64:1325-1333
Analogs of the antimitotic herbicide oryzalin (3,5-dinitro-N4,N4-di-n-propylsulfanilamide) were recently prepared that were more potent in vitro than the parent compound against the kinetoplastid parasite Leishmania donovani (Bioorg Med Chem Lett 12:
Autor:
Robert W. Robey, Tomasz Obrzut, Orsolya Polgar, Suneet Shukla, Attilio Di Pietro, Suresh V. Ambudkar, Julian C. Bahr, Susan E. Bates, Sira Macalou
ABCG2 overexpression has been linked to resistance to topoisomerase inhibitors, leading us to examine the potential interaction between ABCG2 and becatecarin.Interaction with ABCG2 was determined by ATPase assay, competition of [(125)I]iodoarylazidop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfccdaffff31d6902544e4e8c197b7b5
https://europepmc.org/articles/PMC2693460/
https://europepmc.org/articles/PMC2693460/
Autor:
Kenneth Steadman, Suneet Shukla, Susan E. Bates, Elizabeth M. Finley, Tomasz Obrzut, Robert W. Robey, Suresh V. Ambudkar
Publikováno v:
Molecular cancer therapeutics. 6(6)
ABCG2 is a transporter with potential importance in cancer drug resistance, drug oral absorption, and stem cell biology. In an effort to identify novel inhibitors of ABCG2, we examined the ability of commercially available bisindolylmaleimides (BIM)
Autor:
A, Werbovetz Karl, L, Sackett Dan, Dawn, Delfn, Gautam, Bhattacharya, Manar, Salem, Tomasz, Obrzut, Donna, Rattendi, Cyrus, Bacchi
Publikováno v:
Molecular Pharmacology; December 2003, Vol. 64 Issue: 6 p1325-33, 9p